Skip to main content
. 2022 May 5;43(8):5067–5073. doi: 10.1007/s10072-022-06048-1

Table 1.

Demographic and clinical information for individuals with ASDs, patients with FNDs and NA

ASDs
(N =30)
FNDs
(N =21)
NA
(N =45)
Age, mean (SD) 39.7 (12.2) 42.9 (13) 35.4 (11.8)
Sex, M/F 16/14 4/17 28/17
WAIS-IV Verbal Comprehension Index 129.9 (15.9) N/A N/A
WAIS-IV Perceptual Reasoning Index 116.2 (14.4) N/A N/A
AQ, mean (SD) 37.8 (4.3) 15.8 (5.4) 13.5 (6.7)
AQ Clinical, N (%) 30 (100%) 0 (0%) 1 (2.2%)
RAADS-R, mean (SD) 156 (30.1) 44.3 (32.4) 38.1 (32)
RAADS-R Clinical, N (%) 30 (100%) 4 (19%) 7 (15.6%)
FNS Questionnaire, mean (SD) 2.1 (1.5) 3.8 (1.6) 0.7 (1.1)
no FNS, N (%) 4 (13.3%) 0 (0%) 29 (64.4%)
one or more FNS, N (%) 26 (86.7%) 21 (100%) 16 (35.6%)
Loss of consciousness, N (%) 5 (16.7%) 11 (52.4%)

4 (8.9%)

1 missing

Weakness, N (%) 6 (20%) 13 (61.9%) 1 (2.2%)
Paraesthesia, N (%) 15 (50%) 11 (52.4%) 6 (13.3%)
Cognitive disorders, N (%) 0 (0%) 6 (28.6%)

0 (0%)

3 missing

Tremor, N (%) 8 (26.7%) 12 (57.1%) 8 (17.8%)
Chronic pain, N (%) 7 (23.3%) 14 (66.7%) 4 (8.9%)
Chronic Fatigue, N (%) 21 (70%) 17 (82%) 8 (17.8%)
Stuttering, N (%) 0 (0%) 1 (4.8%) 0 (0%)
SPQ-SF35 Total Score, mean (SD) 42.7 (15.5) N/A N/A

Abbreviations: ASDs = Autism Spectrum Disorders group; AQ = Autism Quotient; Clinical = participants scoring above the clinical cut-off; F = female; FNDs = Functional Neurological Disorders group; FNS = Functional Neurological Symptom; M = male; NA = Neurotypical Adults; N/A = not applicable; RAADS-R = Ritvo Autism Asperger Diagnostic Scale-Revised; SD = Standard Deviation; SPQ-SF35 = Sensory Perception Quotient-Short Form; WAIS-IV: Wechsler Adult Intelligent Scale—IV edition.